Disney Donates $15 Million to L.A Fires Relief and Rebuilding Efforts
The Walt Disney Company has committed $15 million to relief and rebuilding efforts for communities impacted by the ongoing L.A. fires.
Related Articles
Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation: cluster randomized controlled trial
Objective To evaluate the effectiveness of multiple decision aid strategies in promoting high quality shared decision making for prevention of stroke in patients with non-valvular…
Artificial Intelligence (AI) and Researchers | Oxford Academic
Anyone with a stake in research—researchers, learned societies, and publishers, to name a few—should be considering an AI-enabled future and their role in
This video company is positioning itself for a world without TikTok
Captions is making a play for CapCut’s users.
Animal Behavior and Cognition | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Neuroprotective Dietary Patterns and Longitudinal Changes in Cognitive Function in Older Adults
Numerous studies have examined the association between neuroprotective diets and cognitive function during aging; however, these studies have produced divergent findings. Some studies find that…
Top digital health funding: Hippocratic AI gets $141M
Hippocratic AI is valued at $1.6 billion as part of the funding round.
Delta Airlines praised for holding flight to allow daughter time with dying mother
The daughter’s TikTok video telling the story received over 10 million views
wqow.com
Eau Claire breaking news, weather and live video. Covering local politics, crime, health, education and sports for Eau Claire and the Chippewa Valley in Wisconsin.
Calls for Papers
Discovery Immunology is an open access journal covering novel discoveries in cellular and molecular immunology, brought to you by the British Society
Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure
Submission of the supplemental NDA was based on positive findings from the FINEARTS-HF trial investigating finerenone for heart failure with an LVEF ≥40%.
